ExcellGene is a Swiss biotechnology company that provides innovative, high-quality solutions for the biopharmaceutical industry. Specialising in mammalian cell line development and protein production, ExcellGene accelerates preclinical development with cutting-edge technology and expertise.

With over 40 years of experience, ExcellGene offers comprehensive services in cell line development, process optimisation, and biosimilar production. The company’s advanced technologies and custom-built solutions ensure efficient, scalable, and cost-effective manufacturing of biologics, particularly proteins, from CHO and HEK 293 cell lines.

Key Products and Services

• CHO and HEK 293 cell line development
• Genome engineering
• cGMP master cell banking
• Process development (USP & DSP)
• Biosimilar development
• Out-licensing of CHOExpress® & HEKExpress® cell hosts

ExcellGene’s commitment to scientific excellence and customer-centric approach makes it a trusted partner in biopharma development, enabling the production of high-quality biologics and biosimilars.